CD180 expression in B‐cell lymphomas: A multicenter GEIL study
暂无分享,去创建一个
M. Béné | L. Miguet | N. Robillard | F. Geneviève | C. Mayeur‐Rousse | J. Guy | F. Solly | L. Mauvieux | S. Bouyer | A. Maar
[1] Taro Kawai,et al. Toll-Like Receptor Signaling Pathways , 2014, Front. Immunol..
[2] F. Lacombe,et al. Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[3] F. Berger,et al. Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas , 2013, Leukemia.
[4] T. Kalina,et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols , 2012, Leukemia.
[5] N. Chiorazzi,et al. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells , 2011, British journal of haematology.
[6] L. Miguet,et al. Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. , 2009, Journal of proteome research.
[7] R. Bataille,et al. Toll-like receptors: lessons to learn from normal and malignant human B cells. , 2008, Blood.
[8] Alain Van Dorsselaer,et al. Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS. , 2006, Journal of proteome research.
[9] A. Tarakhovsky,et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105 , 2005, Nature Immunology.
[10] P. Isaacson,et al. Splenic marginal zone lymphoma. , 1997, Seminars in diagnostic pathology.